About: Septic Shock

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Septic Shock Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Septic Shock
Creator	Kim, Kyuseok Chung, S Choi, H Choi, Han Chung, Sung Kim, Kwon Kwon, W Young, Woon
source	PMC
abstract	For more than 20 years, sepsis has been defined as symptoms associated with the response to microorganism infection, which was more specifically called systemic inflammatory response syndrome (SIRS). With the evidence of organ failure, it was called severe sepsis, and this could lead to hypotension (septic shock). However, with the deep understanding of the pathophysiology of sepsis, sepsis has been known as both inflammatory and anti-inflammatory. Additionally, the classic use of SIRS could lead to overestimation of sepsis. For example, usual common cold could be identified as sepsis in classic definition. With this background, new sepsis definition, Sepsis 3, was introduced and sepsis was defined as a “life-threatening organ dysfunction caused by a dysregulated host response to infection.” The management of sepsis has been changed dramatically, with the development of Surviving Sepsis Campaign, which substantially increased the survival of sepsis. However, this is not with the help of a new drug, but the implementation of a treatment system. Unfortunately, no specific drug for sepsis has survived in clinical use even though many candidate drugs have been successfully investigated in preclinical setting, and this leads to the new approach to the sepsis.
has issue date	2018-08-03(xsd:dateTime)
bibo:doi	10.1007/978-981-10-5406-8_5
has license	no-cc
sha1sum (hex)	8a4de4dcbd9d7f4090586d1df7e216608fd0625d
schema:url	https://doi.org/10.1007/978-981-10-5406-8_5
resource representing a document's title	Septic Shock
has PubMed Central identifier	PMC7121676
schema:publication	Essentials of Shock Management
resource representing a document's body	covid:8a4de4dcbd9d7f4090586d1df7e216608fd0625d#body_text
is schema:about of	named entity 'sepsis' named entity 'SEPSIS' named entity 'ESTIMATION' named entity 'definition' named entity 'incidence' named entity 'Septic Shock' named entity 'crystalloids' named entity 'PEEP' named entity 'severe sepsis' named entity 'vasodilation' named entity 'cardiac output' named entity 'preload' named entity 'qSOFA' named entity 'biomarkers' named entity 'sepsis' named entity 'symptoms and signs' named entity 'biomarker' named entity 'systemic inflammation' named entity 'C-reactive protein' named entity 'sepsis' named entity 'crystalloid' named entity 'cytokines' named entity 'gastrointestinal' named entity 'ICU' named entity 'preload' named entity 'smooth muscle cells' named entity 'Plasma' named entity 'mitochondrial dysfunction' named entity 'organ dysfunction' named entity 'sepsis' named entity 'fluid shift' named entity 'beta-blockers' named entity 'tissue hypoxia' named entity 'aerobic' named entity 'TNF-α' named entity 'IVC' named entity 'immune cell' named entity 'nuclear factor' named entity 'nitric oxide' named entity '5.4' named entity 'Autonomic' named entity 'SIRS' named entity 'sepsis' named entity 'acute-phase reactants' named entity 'hormone' named entity 'end-stage' named entity 'norepinephrine' named entity '95.2%' named entity 'Vasopressin' named entity 'septic shock' named entity 'sepsis' named entity 'AUROC' named entity 'CVP' named entity 'sepsis' named entity '5.2' named entity 'vasopressor' named entity 'ng/mL' named entity 'sepsis' named entity 'Streptococcus' named entity 'CVP' named entity 'adipose tissues' named entity 'mmHg' named entity 'acute kidney injury' named entity 'CURB-65' named entity 'Serum' named entity 'advanced technology' named entity 'secondary infection' named entity 'sodium' named entity 'inflammation' named entity 'insulin secretion' named entity 'beta-adrenergic' named entity 'vasoactive' named entity 'diarrhea' named entity 'sepsis' named entity 'antimicrobial therapy' named entity 'mitochondrial dysfunction'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software